Isfahan University of Medical Sciences Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2013
NCT02226913
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now